Zobrazeno 1 - 10
of 100
pro vyhledávání: '"U. F. Habenicht"'
Autor:
B. Mueller, U.-F. Habenicht
Publikováno v:
Andrologia. 20:23-32
Summary: It could be demonstrated with the aid of a cheek pouch model of the hamster that the LHRH-agonist lutrelin (Wyeth, WY 40972) caused disturbances of microcirculation within minutes, for example constriction of the arterioles and venules, redu
Publikováno v:
Andrologia. 19:602-613
Summary: The treatment of adult male Wistar rats with a LHRH-agonist (lutrelin Wyeth/WY 40972) resulted in severe damage of the seminiferous tubules as well as in remarkable changes of the blood vessels within 24 hours. First striking signs of altera
Publikováno v:
Human Reproduction (Oxford, England)
BACKGROUND: The role of the immune system in the pathogenesis of endometriosis remains elusive. It has been shown that patients have an altered peritoneal environment with increased levels of inflammatory cytokines, activated macrophages and reduced
Autor:
Terry T. Turner, Russell C. jones, V.G. Da Ros, Minjie Lin, Sylvie Breton, Suresh Yenugu, E. Chabory, Jean-Louis Dacheux, Åke Lundwall, Matti Poutanen, P. S. Cuasnicu, Y. Lanson, Joshua N. Finger, C. Cook, Heath Ecroyd, R. Jones, J. L. Dacheux, A. Bhardwaj, Jose L. Tomsig, D. W. Hamilton, M. M. Galdamez, Patrick Vernet, M. Jacob, F. Dacheux, S. Vijayaraghavan, M. A. Nolan, S. A. Jelinsky, M. Christina, Daniel G. Cyr, S. A. Lamour, Barry T. Hinton, Fabrice Saez, Mark Baker, D. J. Cohen, J. Maclean, M. Belghaz, D. Busso, H. Hamzeh, H. W. Song, Xiuping Yu, Joël R. Drevet, K. P. Roberts, J. L. Wooters, Jean-Marc A. Lobaccaro, D. S. Johnston, Frank S. French, T. G. Cooper, S. Shanker, B. Robaire, Kichiya Suzuk, Susan H. Hall, Peter Petrusz, N. Goldweic, D. Bomgardner, Kenneth P. Roberts, Julie Girouard, Robert J. Matusik, Gail A. Cornwall, T. T. Turner, Gilles Frenette, L. B. Piehl, R. John Aitken, U. F. Habenicht, K. Barteczko, Rémi Cadet, J. Gipp, Yun Hwa Lee, M. F. Wilkinson, U. Gottwald, J. Maldera, Brett Nixon, Marie-Claire Orgebin-Crist, Daniel S. Johnston, W. Bushman, Scott A. Jelinsky, Yashwanth Radhakrishnan, Hiroko Takano, Robert Sullivan, S. Seenundun, David W. Hamilton, K. M. Ensrud, W. Avellar, G. Langer
Publikováno v:
Andrologie. 17:154-173
Publikováno v:
Molecular and Cellular Endocrinology. 216:1-4
In 1997, the Rockefeller Foundation and the Ernst Schering Research Foundation (a subsidiary of Schering AG, Germany, on a non-profit basis) mounted a multi-year global collaborative effort, involving a network of top-level research institutions to i
Autor:
U.-F. Habenicht
Publikováno v:
The Aging Male. 1:73-79
The role of estrogens in male physiology has received little attention until recently. However, it is now becoming more and more evident that estrogens are jar more important for a normal junction of reproduction and non-reproductive junctions in men
Autor:
M.F. El Etreby, U.-F. Habenicht
Publikováno v:
Neuroendocrinology of Sex Steroids: Basic Knowledge and Clinical Implications
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d1cb0fa6fe91c55a9f51b58574ebc85
https://doi.org/10.1515/9783110887648.135
https://doi.org/10.1515/9783110887648.135
Publikováno v:
The Journal of Steroid Biochemistry and Molecular Biology. 37:937-942
The ability of the new LHRH antagonist antide to induce a long-term chemical castration in adult male rats and cynomolgus monkeys was investigated. The animals were treated subcutaneously with different doses either once or on 5 consecutive days. The
Autor:
Horst Michna, Yukishige Dr Nishino, U.-F. Habenicht, Kunhard Pollow, Martin R. Schneider, Hans Jörg Grill
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 118:187-189
The progesterone antagonist Onapristone proved to possess strong tumour-inhibiting activity in a panel of experimental mammary carcinomas. Its underlying mechanism of action is due to a progesterone-receptor-mediated induction of terminal differentia
Autor:
G. Stock, U.-F. Habenicht
Publikováno v:
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 67
Drug development within the pharmaceutical industry is probably the field with the highest level of regulations. Due to the complexity of the different components of drug development and drug surveillance the need for a sophisticated organization and